The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells

Acta Biochimica et Biophysica Sinica

Volumn 48, Issue 6, 2016, Pages 528-535

  Hu, Song ^a   Li, Xiaolin ^a   Xu, Rongrong ^a   Ye, Lingyun ^a   Kong, Hui ^a   Zeng, Xiaoning ^a   Wang, Hong ^a   Xie, Weiping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Cisplatin; Non small cell lung cancer; Resveratrol

Indexed keywords

3-METHYLADENINE; ADENINE; CISPLATIN; MAP1LC3A PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; P62 PROTEIN, HUMAN; PROTEIN KINASE B; RESVERATROL; RNA BINDING PROTEIN; STILBENE DERIVATIVE; TUMOR PROTEIN;

A-549 CELL LINE; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ANALOGS AND DERIVATIVES; APOPTOSIS; AUTOPHAGOSOME; AUTOPHAGY; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; LUNG NEOPLASMS; METABOLISM; PATHOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

A549 CELLS; ADENINE; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; APOPTOSIS; AUTOPHAGOSOMES; AUTOPHAGY; CISPLATIN; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA-BINDING PROTEINS; STILBENES;

EID: 84979220711     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmw026     Document Type: Article

References (35)

1. Sacco PC, Casaluce F, Sgambato A, Rossi A, Maione P, Palazzolo G, Napolitano A. Current challenges of lung cancer care in an aging population. Expert Rev Anticancer Ther 2015, 15: 1419-1429.
2. Ettinger D, Wood DE, Akerley W, Bazhenova LA, Borghaei H, Camidge DR, Cheney RT, et al. Non-small cell lung cancer, version 6.2015. J Natl Compr Canc Netw 2015, 13: 515-524.
3. NSCLC Meta-Analyses Collaborative Group. Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. J Clin Oncol 2008, 26: 4617-4625.
4. van den Berg JH, Beijnen JH, Balm AJ, Schellens JH. Future opportunities in preventing cisplatin induced ototoxicity. Cancer Treat Rev 2006, 32: 390-397.
5. Mukhopadhyay P, Choi YM, Kim HK, Shim W, Anwar MA, Kwon JW, Kwon HK, et al. Mechanism of cisplatin-induced cytotoxicity is correlated to impaired metabolism due to mitochondrial ROS generation. PLoS One 2015, 10: e0135083.
6. Kohno K, Wang KY, Takahashi M, Kurita T, Yoshida Y, Hirakawa M, Harada Y, et al. Mitochondrial transcription factor A and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy. Int J Mol Sci 2015, 16: 19836-19850.
7. Liu M, Qi Z, Liu B, Ren Y, Li H, Yang G, Zhang Q. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway. Oncotarget 2015, 6: 25281-25294.
8. Li W, Melton DW. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance. Oncogene 2012, 31: 2412-2422.
9. Lo SJ, Fan LC, Tsai YF, Lin KY, Huang HL, Wang TH, Liu H, et al. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells. Hepatology 2013, 57: 1893-1905.
10. Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, et al. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 2008, 27: 4221-4232.
11. Novelle MG, Wahl D, Dieguez C, Bernier M, de Cabo R. Resveratrol supplementation: where are we now and where should we go? Ageing Res Rev 2015, 21: 1-15.
12. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol 2012, 3: 141.
13. Cai H, Scott E, Kholghi A, Andreadi C, Rufini A, Karmokar A, Britton RG, et al. Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Sci Transl Med 2015, 7: 298ra117.
14. Oi N, Yuan J, Malakhova M, Luo K, Li Y, Ryu J, Zhang L, et al. Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene 2015, 34: 2660-2671.
15. Alkhalaf M, Jaffal S. Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: novel cellular mechanisms involving the ERKs/p53 cascade. Free Radic Biol Med 2006, 41: 318-325.
16. Tsai JH, Hsu LS, Lin CL, Hong HM, Pan MH, Way TD, Chen WJ. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/beta-catenin signaling cascades and reversal of epithelialmesenchymal transition. Toxicol Appl Pharmacol 2013, 272: 746-756.
17. Filomeni G, Graziani I, Rotilio G, Ciriolo MR. trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways. Genes Nutr 2007, 2: 295-305.
18. Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K, Tsubura A. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 2012, 40: 1020-1028.
19. Karch J, Molkentin JD. Regulated necrotic cell death: the passive aggressive side of Bax and Bak. Circ Res 2015, 116: 1800-1809.
20. Radogna F, Dicato M, Diederich M. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target. Biochem Pharmacol 2015, 94: 1-11.
21. Schneider JL, Cuervo AM. Autophagy and human disease: emerging themes. Curr Opin Genet Dev 2014, 26: 16-23.
22. Hale AN, Ledbetter DJ, Gawriluk TR, Rucker EBIII. Autophagy: regulation and role in development. Autophagy 2013, 9: 951-972.
23. Apel A, Zentgraf H, Buchler MW, Herr I. Autophagy-A double-edged sword in oncology. Int J Cancer 2009, 125: 991-995.
24. Jin M, Klionsky DJ. Regulation of autophagy: modulation of the size and number of autophagosomes. FEBS Lett 2014, 588: 2457-2463.
25. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 2004, 36: 2503-2518.
26. Katsuragi Y, Ichimura Y, Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J 2015, 282: 4672-4678.
27. Xing C, Zhu B, Liu H, Yao H, Zhang L. Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. Acta Biochim Biophys Sin 2008, 40: 194-201.
28. Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, et al. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis 2013, 34: 1331-1342.
29. Fu LL, Cheng Y, Liu B. Beclin-1: autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol 2013, 45: 921-924.
30. Naves T, Jawhari S, Jauberteau MO, Ratinaud MH, Verdier M. Autophagy takes place in mutated p53 neuroblastoma cells in response to hypoxia mimetic CoCl(2). Biochem Pharmacol 2013, 85: 1153-1161.
31. Hsu CM, Tsai Y, Wan L, Tsai FJ. Bufalin induces G2/M phase arrest and triggers autophagy via the TNF, JNK, BECN-1 and ATG8 pathway in human hepatoma cells. Int J Oncol 2013, 43: 338-348.
32. Pan WR, Chen PW, Chen YL, Hsu HC, Lin CC, Chen WJ. Bovine lactoferricin B induces apoptosis of human gastric cancer cell line AGS by inhibition of autophagy at a late stage. J Dairy Sci 2013, 96: 7511-7520.
33. Zou W, Wang X, Vale RD, Ou G. Autophagy genes promote apoptotic cell corpse clearance. Autophagy 2012, 8: 1267-1268.
34. Pedro JM, Wei Y, Sica V, Maiuri MC, Zou Z, Kroemer G, Levine B. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy 2015, 11: 452-459.
35. Mukhopadhyay S, Panda PK, Sinha N, Das DN, Bhutia SK. Autophagy and apoptosis: where do they meet? Apoptosis 2014, 19: 555-566.